950140 fundamentals

Key facts

Market capitalization‪137.49 B‬KRW
Founded2015
CEOJohn Hwa Kim
About

Englewood Lab, Inc. engages in the manufacture and sale of skin care products such as oils, creams, serums, cleansers and masks. The company was founded on August 20, 2015 and is headquartered in Englewood, NJ.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪137.49 B‬‬
Price to earning ratio (P/E)
9.26x
Price to sales ratio (P/S)
0.70x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
9.26x
Price to sales ratio (P/S)
0.70x
Valuation ratios
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪5.50‬
‪11.00‬
‪16.50‬
‪22.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪1%‬
‪5%‬
‪9%‬
‪13%‬
‪17%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪15.00 B‬‬
‪‪30.00 B‬‬
‪‪45.00 B‬‬
‪‪60.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪11.00 B‬‬
‪‪22.00 B‬‬
‪‪33.00 B‬‬
‪‪44.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪11.00 B‬‬
‪‪22.00 B‬‬
‪‪33.00 B‬‬
‪‪44.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Basic Cosmetics
Functional Cosmetics and Quasi-Drugs (Over the Counter))
Color Cosmetics
Other
Service
By country
Period: 2023
Unites States
South Korea
Europe
Canada
Southeast Asia
Other
China

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
2019
2020
2021
‪0.00‬
‪‪40.00 B‬‬
‪‪80.00 B‬‬
‪‪120.00 B‬‬
‪‪160.00 B‬‬
Actual
Estimate
Earnings
Next:Mar 12
2019
2020
2021
‪−800.00‬
‪−400.00‬
‪0.00‬
‪400.00‬
‪800.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
13.53%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
1.46%
Last payment
101.00
Last ex-date
Dec 27, 2023
Dividend history
‪0.0%‬
‪0.2%‬
‪0.4%‬
‪0.6%‬
‪0.8%‬
2019
2020
2021
2022
2023
‪0.00‬
‪26.00‬
‪52.00‬
‪78.00‬
‪104.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−11.00 B‬‬
‪0.00‬
‪‪11.00 B‬‬
‪‪22.00 B‬‬
‪‪33.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪35.00 B‬‬
‪‪70.00 B‬‬
‪‪105.00 B‬‬
‪‪140.00 B‬‬
Assets
Liabilities